Cover Image
市場調查報告書

體外式薄膜型人工肺 (ECMO) 系統的全球市場的預測 ∼2020年:各模式 (VA、VV、AV)、用途 (呼吸系統、心臟、ECPR)、地區

Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), by Application (Respiratory, Cardiac, ECPR), by Geography - Global Forecast to 2020

出版商 MarketsandMarkets 商品編碼 347366
出版日期 內容資訊 英文 139 Pages
訂單完成後即時交付
價格
Back to Top
體外式薄膜型人工肺 (ECMO) 系統的全球市場的預測 ∼2020年:各模式 (VA、VV、AV)、用途 (呼吸系統、心臟、ECPR)、地區 Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), by Application (Respiratory, Cardiac, ECPR), by Geography - Global Forecast to 2020
出版日期: 2015年12月15日 內容資訊: 英文 139 Pages
簡介

全球體外式薄膜型人工肺 (ECMO) 系統的市場,2014年記錄了2億2770萬美元的規模。從2015年到2020年預計以4.0%的年複合成長率發展,2020年成長到2億8760萬美元的規模。2014年的各地區佔有率是北美最大,呼吸衰竭和心肺性疾病患者的增加、慢性阻塞性肺病的發病率擴大、醫院的ECMO設備的引進率擴大、ECMO技術的發展等要素,對這個成長有所貢獻。

本報告提供全球體外式薄膜型人工肺 (ECMO) 系統的市場相關調查、相關的疾病和系統概要、市場成長的各種推動因素&阻礙要素及市場機會分析、各模式/用途/地區/主要國家的主要趨勢及市場規模的變化與預測、競爭環境,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場概要

  • 市場促進因素&阻礙要素
  • ECMO的威脅
  • 未來市場機會

第5章 市場分析:各種模式

  • 簡介
  • 靜脈、動脈 (VA) 方式
  • 靜脈、靜脈 (VV) 方式
  • 動脈、靜脈 (AV) 方式

第6章 市場分析:各用途

  • 簡介
  • 呼吸系統
    • 新生兒
    • 小兒科
    • 成人
  • 心臟
    • 新生兒
    • 小兒科
    • 成人
  • 體外循環式心肺甦醒 (ECPR)
    • 新生兒
    • 小兒科
    • 成人

第7章 地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙瑞士
    • 其他
  • 亞太地區
    • 日本
    • 澳洲
    • 中國
    • 印度
    • 新加坡
    • 韓國
    • 其他
  • 其他

第8章 競爭環境

  • 新產品的開發、投入
  • 協定、收購、聯盟
  • 擴張
  • 其他

第9章 企業簡介

  • MAQUET HOLDING B.V. & CO. KG.
  • MEDTRONIC, INC.
  • MICROPORT SCIENTIFIC CORPORATION
  • TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
  • MEDOS MEDIZINTECHNIK AG
  • Nipro
  • SORIN GROUP (SORIN S.P.A.)
    • 概要
    • 財務趨勢
    • 產品與服務
    • 發展趨勢
    • MNM的見解等

第10章 附錄

圖表清單

目錄
Product Code: MD 3966

The global extracorporeal membrane oxygenation (ECMO) system market accounted for USD 227.7 million in 2014 and is expected to reach USD 287.6 million by 2020 at a CAGR of 4.0% from 2015 to 2020.

The purpose of this report is to cover the definition, description, and forecast of Global Extracorporeal Membrane Oxygenation (ECMO) System market. It involves deep dive analysis of market segmentation which comprises of submarkets, modality and application. The report also offers strategic analysis of key players in the market. In this report, the Extracorporeal Membrane Oxygenation (ECMO) System market is segmented on the basis of its modality and application. In terms of modality, the market is segmented into Veno Artrial (VA), Veno Venous (VV), Artrio Venous (ECOO2 R).

This market has been segmented by application, which includes Respiratory, Cardiac, and Extra-Corporeal Cardiopulmonary Resuscitation (ECPR). The respiratory segment was the largest application of the global Extracorporeal Membrane Oxygenation (ECMO) System market in 2014.

Globally, North America contributed to the largest Extracorporeal Membrane Oxygenation (ECMO) System market in 2014. The large share is attributed to rise in the increasing number of patients suffering from respiratory failure and cardiopulmonary disease, rising incidence in Chronic Obtrusive Pulmonary Diseases (COPD), increasing adoption rate of ECMO machine in hospitals, technological advancements in ECMO system, success rate of ECMO and government initiatives and growing awareness towards ECMO. All these factors would help improve the demand of ECMO machines, which are used on a small scale in hospitals currently.

Furthermore, increasing number of patients suffering from respiratory failure and cardiopulmonary disease are other growth factors. With the rising number of cases globally, there is a boost in the growth of extra corporeal membrane oxygenators market. Respiratory failure may affect the muscles, nerves, bones, or tissues that support breathing, or they may affect the lungs directly. Over 3 million Canadians of all ages have a serious respiratory disease such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, tuberculosis (TB), cystic fibrosis, and respiratory distress syndrome. More than 5 million patients are admitted annually to ICUs in the U.S. In 2010, cardiovascular, lung, and blood diseases accounted for 1,017,000 deaths and 41 percent of all deaths in the U.S. However, cost of high end equipment, presence of conventional techniques, risk of complications, renal failure associated with ECMO are some of the restraints for the Extracorporeal Membrane Oxygenation (ECMO) System market.

The report also provides a detailed competitive landscaping of companies operating in this market. It also offers segment and country specific company shares, news & deals, M&A, segment specific pipeline products, product approvals and product recalls of major companies. The main companies operating in this market are MAQUET Holding B.V. & CO. KG. (Germany), SORIN Group (Italy), MEDTRONIC (Republic of Ireland), NIPRO Medical Corporation (U.S.), Terumo Medical Corporation (Japan), MicroPort Scientific Corporation (China), Medos Medizintechnik AG (Germany).

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles. Also, the report covers basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities in the Extracorporeal Membrane Oxygenation (ECMO) System market.

The report offers detailed information on new entrants/smaller firms to gauge the pulse of the market, which in turn helps garner the market share. The firms purchasing the report could use any one or a combination of the below mentioned five strategies to strengthen their market share.

The report provides insights on the following pointers:

  • Product Analysis and Development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the market.
  • Market Development: Offers comprehensive information about lucrative emerging markets. Analysis of market across various regions; distribution channels, clientele base and pricing policies involved vis-a-vis geographies.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions. Detailed description regarding the related and unrelated diversification pertaining to the market.
  • Competitive Assessment: An in-depth assessment of market shares and company share analyses of the key players projected till 2020. Business strategies and manufacturing capabilities of leading players are also provided.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET SEGMENTATION & COVERAGE
  • 1.3. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. INTEGRATED ECOSYSTEM OF THE EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET
  • 2.2. ARRIVING AT THE EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET SIZE
    • 2.2.1. TOP-DOWN APPROACH
    • 2.2.2. MACRO INDICATOR- BASED APPROACH
  • 2.3. PRICE ANALYSIS OF EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY PRODUCT
  • 2.4. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. MARKET OVERVIEW

  • 4.1. MARKET DRIVERS AND INHIBITORS
  • 4.2. THREATS OF ECMO
  • 4.3. OPPORTUNITIES IN FUTURE

5. EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY

  • 5.1. INTRODUCTION
  • 5.2. VENO-ARTERIAL
  • 5.3. VENO-VENOUS
  • 5.4. ARTERIO-VENOUS (AV)

6. EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION

  • 6.1. INTRODUCTION
  • 6.2. RESPIRATORY
    • 6.2.1. NEONATES
    • 6.2.2. PEDIATRIC
    • 6.2.3. ADULT
  • 6.3. CARDIAC
    • 6.3.1. NEONATES
    • 6.3.2. PEDIATRIC
    • 6.3.3. ADULT
  • 6.4. EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)
    • 6.4.1. NEONATES
    • 6.4.2. PEDIATRIC
    • 6.4.3. ADULT

7. EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY

  • 7.1. INTRODUCTION
  • 7.2. NORTH AMERICA
    • 7.2.1. U.S.
    • 7.2.2. CANADA
    • 7.2.3. MEXICO
  • 7.3. EUROPE
    • 7.3.1. GERMANY
    • 7.3.2. U.K.
    • 7.3.3. FRANCE
    • 7.3.4. ITALY
    • 7.3.5. SPAIN
    • 7.3.6. SWITZERLAND
    • 7.3.7. REST OF EUROPE (ROE)
  • 7.4. ASIA-PACIFIC (APAC)
    • 7.4.1. JAPAN
    • 7.4.2. AUSTRALIA
    • 7.4.3. CHINA
    • 7.4.4. INDIA
    • 7.4.5. SINGAPORE
    • 7.4.6. REPUBLIC OF KOREA
    • 7.4.7. REST OF ASIA-PACIFIC
  • 7.5. REST OF THE WORLD (ROW)

8. COMPETITIVE LANDSCAPE

    • 8.1.1. NEW PRODUCT LAUNCH & PRODUCT DEVELOPMENT
    • 8.1.2. AGREEMENT, ACQUISITION & PARTNERSHIP
    • 8.1.3. EXPANSION
    • 8.1.4. OTHER

9. COMPANY PROFILES

  • 9.1. MAQUET HOLDING B.V. & CO. KG.
    • 9.1.1. OVERVIEW
    • 9.1.2. KEY FINANCIALS
    • 9.1.3. PRODUCT AND SERVICE OFFERINGS
    • 9.1.4. RELATED DEVELOPMENTS
    • 9.1.5. MNM VIEW
  • 9.2. MEDTRONIC, INC. (U.S.)
    • 9.2.1. OVERVIEW
    • 9.2.2. KEY FINANCIALS
    • 9.2.3. PRODUCT AND SERVICE OFFERINGS
    • 9.2.4. RELATED DEVELOPMENTS
    • 9.2.5. MNM VIEW
  • 9.3. MICROPORT SCIENTIFIC CORPORATION
    • 9.3.1. OVERVIEW
    • 9.3.2. KEY FINANCIALS
    • 9.3.3. PRODUCT AND SERVICE OFFERINGS
    • 9.3.4. MNM VIEW
  • 9.4. TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
    • 9.4.1. OVERVIEW
    • 9.4.2. KEY FINANCIALS
    • 9.4.3. PRODUCT AND SERVICE OFFERINGS
    • 9.4.4. RELATED DEVELOPMENTS
    • 9.4.5. MNM VIEW
  • 9.5. MEDOS MEDIZINTECHNIK AG
    • 9.5.1. OVERVIEW
    • 9.5.2. PRODUCT AND SERVICE OFFERINGS
    • 9.5.3. RELATED DEVELOPMENTS
    • 9.5.4. MNM VIEW
  • 9.6. NIPRO MEDICAL CORPORATION
    • 9.6.1. OVERVIEW
    • 9.6.2. KEY FINANCIALS
    • 9.6.3. PRODUCT AND SERVICE OFFERINGS
    • 9.6.4. RELATED DEVELOPMENTS
    • 9.6.5. MNM VIEW
  • 9.7. SORIN GROUP (SORIN S.P.A.)
    • 9.7.1. OVERVIEW
    • 9.7.2. SORIN GROUP: KEY FINANCIALS
    • 9.7.3. PRODUCT AND SERVICE OFFERINGS
    • 9.7.4. RELATED DEVELOPMENTS
    • 9.7.5. MNM VIEW

10. APPENDIX

  • 10.1. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 10.2. CUSTOMIZATION OPTIONS
    • 10.2.1. PRODUCT ANALYSIS
    • 10.2.2. PULMONOLOGIST/PHYSICIANS PERCEPTION ANALYSIS
    • 10.2.3. REGULATORY FRAMEWORK
    • 10.2.4. COMPETITIVE INTELLIGENCE
  • 10.3. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET: MACRO INDICATORS, BY COUNTRY, 2014 (USD MILLION)
  • TABLE 2: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET: DRIVERS AND INHIBITORS
  • TABLE 3: EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 4: VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 5: VENO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 6: ARTERIO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 7: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 8: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)
  • TABLE 9: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)
  • TABLE 10: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR, BY AGE GROUP, 2013-2020 (USD MILLION)
  • TABLE 11: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION)
  • TABLE 12: NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 13: NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 14: NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)
  • TABLE 15: NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)
  • TABLE 16: NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)
  • TABLE 17: U.S.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 18: U.S.: EXTRA CORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 19: CANADA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 20: CANADA: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 21: MEXICO: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 22: MEXICO: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 23: EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 24: EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 25: EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)
  • TABLE 26: EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)
  • TABLE 27: EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)
  • TABLE 28: GERMANY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 29: GERMANY: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 30: U.K.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 31: U.K.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 32: FRANCE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 33: FRANCE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 34: ITALY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 35: ITALY: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 36: SPAIN: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 37: SPAIN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 38: SWITZERLAND: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 39: SWITZERLAND: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 40: ROE: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 41: ROE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 42: APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 43: APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 44: APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)
  • TABLE 45: APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)
  • TABLE 46: APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)
  • TABLE 47: JAPAN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 48: JAPAN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 49: AUSTRALIA: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 50: AUSTRALIA: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 51: CHINA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 52: CHINA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 53: INDIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 54: INDIA: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 55: SINGAPORE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 56: SINGAPORE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 57: REPUBLIC OF KOREA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 58: REPUBLIC OF KOREA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 59: REST OF APAC: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 60: REST OF APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 61: ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 62: ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION)
  • TABLE 63: ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)
  • TABLE 64: ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)
  • TABLE 65: ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION)
  • TABLE 66: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET, BY COMPANY, 2014 (%)
  • TABLE 67: MAQUET HOLDING B.V. & CO. KG.: KEY FINANCIALS, BY BUSINESS SEGMENT, 2012-2014 (USD MN)
  • TABLE 68: MAQUET HOLDING B.V. & CO. KG.: KEY FINANCIALS, BY GEOGRAPHY, 2012-2014 (USD MN)
  • TABLE 69: MEDTRONIC, INC. : KEY FINANCIALS, BY BUSINESS SEGMENT, 2012-2014 (USD MN)
  • TABLE 70: MEDTRONIC, INC.: KEY FINANCIALS, BY GEOGRAPHY, 2012-2014 (USD MN)
  • TABLE 71: MICROPORT SCIENTIFIC CORPORATION: KEY FINANCIALS, BY BUSINESS SEGMENT, 2012-2014 (USD MN)
  • TABLE 72: MICROPORT SCIENTIFIC CORPORATION: KEY FINANCIALS, BY GEOGRAPHY, 2012-2014 (USD MN)
  • TABLE 73: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: KEY FINANCIALS, BY BUSINESS SEGMENT, 2012-2014 (USD MN)
  • TABLE 74: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: KEY FINANCIALS, BY GEOGRAPHY, 2012-2014 (USD MN)
  • TABLE 75: NIPRO MEDICAL CORPORATION: KEY FINANCIALS, BY BUSINESS SEGMENT, 2011-2014 (USD MN)
  • TABLE 76: SORIN GROUP: KEY FINANCIALS, BY BUSINESS SEGMENT, 2013-2014 (USD MN)
  • TABLE 77: SORIN GROUP: KEY FINANCIALS (CARDIAC SURGERY), BY BUSINESS SUB-SEGMENT, 2013-2014 (USD MN)
  • TABLE 78: SORIN GROUP: KEY FINANCIALS, BY GEOGRAPHY, 2013-2014 (USD MN)

LIST OF FIGURES

  • FIGURE 1: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET SEGMENTATION & COVERAGE
  • FIGURE 2: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET: INTEGRATED ECOSYSTEM
  • FIGURE 3: ARRIVING AT THE EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET SIZE
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: MACRO INDICATOR-BASED APPROACH
  • FIGURE 6: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET SNAPSHOT
  • FIGURE 7: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY MODALITY, 2014 & 2020 (USD MILLION)
  • FIGURE 8: VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY, 2015 & 2020 (USD MILLION)
  • FIGURE 9: VENO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY, 2015 & 2020 (USD MILLION)
  • FIGURE 10: ARTERIO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY GEOGRAPHY, 2015 & 2020 (USD MILLION)
  • FIGURE 11: INDICATIONS WHERE ECMO IS USED
  • FIGURE 12: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2014 & 2020 (USD MILLION)
  • FIGURE 13: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)
  • FIGURE 14: NEONATAL SURVIVAL RATE, EXTRACORPOREAL LIFE SUPPORT ORGANIZATION (ELSO) DATA (1987-1993)
  • FIGURE 15: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)
  • FIGURE 16: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR, BY AGE GROUP, 2015 & 2020 (USD MILLION)
  • FIGURE 17: EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO): GROWTH ANALYSIS, BY GEOGRAPHY, 2014-2020 (USD MILLION)
  • FIGURE 18: NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 19: NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)
  • FIGURE 20: NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)
  • FIGURE 21: NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)
  • FIGURE 22: U.S.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 23: U.S.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 24: U.S.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 25: CANADA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 26: CANADA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 27: CANADA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 28: MEXICO: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 29: MEXICO: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 30: MEXICO: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 31: EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 32: EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)
  • FIGURE 33: EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)
  • FIGURE 34: EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)
  • FIGURE 35: GERMANY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 36: GERMANY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 37: GERMANY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 38: U.K.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 39: U.K.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 40: U.K.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 41: FRANCE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 42: FRANCE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 43: FRANCE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 44: ITALY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 45: ITALY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 46: ITALY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 47: SPAIN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 48: SPAIN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 49: SPAIN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 50: SWITZERLAND: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 51: SWITZERLAND: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 52: SWITZERLAND: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 53: ROE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 54: ROE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 55: ROE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 56: APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 57: APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)
  • FIGURE 58: APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)
  • FIGURE 59: APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)
  • FIGURE 60: JAPAN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 61: JAPAN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 62: JAPAN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 63: AUSTRALIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 64: AUSTRALIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 65: AUSTRALIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 66: CHINA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 67: CHINA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 68: CHINA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 69: INDIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 70: INDIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 71: INDIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 72: SINGAPORE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 73: SINGAPORE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 74: SINGAPORE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 75: REPUBLIC OF KOREA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 76: REPUBLIC OF KOREA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 77: REPUBLIC OF KOREA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 78: REST OF APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 79: REST OF APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 & 2020 (USD MILLION)
  • FIGURE 80: REST OF APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 & 2020 (USD MILLION)
  • FIGURE 81: ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 & 2020 (%)
  • FIGURE 82: ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)
  • FIGURE 83: ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)
  • FIGURE 84: ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2015 & 2020 (USD MILLION)
  • FIGURE 85: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET, BY COMPANY, 2014 (%)
  • FIGURE 86: MAQUET HOLDING B.V. & CO. KG.: REVENUE MIX, 2014 (%)
  • FIGURE 87: MEDTRONIC, INC.: REVENUE MIX, 2014 (%)
  • FIGURE 88: MICROPORT SCIENTIFIC CORPORATION: REVENUE MIX, 2014 (%)
  • FIGURE 89: TERUMO CORPORATION: REVENUE MIX, 2014 (%)
  • FIGURE 90: NIPRO MEDICAL CORPORATION: REVENUE MIX, 2014 (%)
  • FIGURE 91: SORIN GROUP: REVENUE MIX, 2014 (%)
Back to Top